Inhibition of Grb2 and Crkl Proteins Results in Growth Inhibition of Philadelphia Chromosome Positive Leukemic Cells
- 18 June 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 235 (2) , 383-388
- https://doi.org/10.1006/bbrc.1997.6791
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The CRKL Adaptor Protein Transforms Fibroblasts and Functions in Transformation by the BCR-ABL OncogenePublished by Elsevier ,1996
- The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.Proceedings of the National Academy of Sciences, 1995
- Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of ApoptosisMolecular and Cellular Biology, 1995
- Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogeneCell, 1995
- BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]Blood, 1994
- Acute leukaemia in bcr/abl transgenic miceNature, 1990
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.Molecular and Cellular Biology, 1989
- The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activityVirology, 1985
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984